NVST — AI Stock Forecast & Price Targets

Published 8/23/2026 · A free sample of K3vl4r’s AI-powered analysis.

Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.

View the live NVST price forecast →

NVST shows strong operational momentum and growth potential in specialty dental products but faces elevated valuation and debt risks. Recent earnings beats and leadership changes support near-term upside, though macroeconomic headwinds and high leverage temper longer-term prospects. The technical chart indicates consolidation with a bearish forecast band, creating uncertainty for short-term traders.

ACCUMULATE
low convictiongenerated 8/23/2026, 3:11:55 PM
Scores
Fundamentals
7.0
Technicals
5.5
Growth potential
7.5
Risk
6.3
Overall
6.0
Charts the model saw
Bear
$22.96
Base
$27.85
Bull
$32.28
over ~6 months
Investment plan
Short term · 1-4 weeks

Hold near current price ($27.20) with stop-loss at $24.91; invalidation if price breaks below $24.91 or fails to hold above $26.93

Mid term · 1-6 months

Accumulate on dips below $25.00; target $30.57 (Zacks PT) by Q4 2026, driven by earnings beats and global expansion.

Long term · 1-3 years

Long-term value hinges on deleveraging progress and sustained growth in specialty products; structural risk is high if tariffs or macroeconomic downturns impact international sales.

Fundamentals

Revenue growth is robust (11.89% YoY) with strong gross margins (55.86%) and improving operating margins (10.61%). However, high debt-to-equity (51.62%) and elevated P/E (47.26) create valuation concerns. Cash flow is healthy ($275.7M FCF), but the 3-year performance (-17.80%) suggests cyclical vulnerability. Recent guidance hikes for 2026 indicate management confidence, though China tariffs and Q4 challenges loom.

Technicals

The chart shows a bullish trend with recent consolidation near $27.20 (actual price), but the Kronos AI forecast band (yellow) indicates potential downside to $24.91. Support at $24.91 is critical; breaking below could trigger further declines. The 52-week range ($18.77-$30.42) shows significant upside potential, though current momentum is neutral with RSI at 48.23.

News read

Key news includes Envista's leadership changes (CEO as Chairman), strong Q2 results (revenue $730.5M up 7.1%), and guidance hikes for 2026. However, China tariffs and macroeconomic risks are significant concerns. Retail sentiment is overwhelmingly bullish, but the technical chart suggests near-term consolidation.

Growth / roadmap
  • Q3 revenue guidance of $730.5M (up 7.1% YoY) driven by strong specialty product demand
  • China tariff impacts on global sales, with management highlighting resilience in dental care demand
Risks
  • High debt-to-equity ratio (51.62%) amplifies downside risk during macroeconomic stress
  • Tariffs and currency volatility threaten international growth momentum

Get AI analysis on any stock

This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.